Identification of HLA-Cw6.02 and HLA-Cw7.01 allele-specific binding motifs by screening synthetic peptide libraries

被引:12
作者
Dionne, SO
Lake, DF
Grimes, WJ
Smith, MH
机构
[1] Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA
[2] Univ Arizona, Arizona Canc Ctr, Dept Microbiol & Immunol, Tucson, AZ 85724 USA
关键词
HLA-Cw7; HLA-Cw6; peptide motif; combinatorial peptide library;
D O I
10.1007/s00251-004-0710-1
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学]; 090102 [作物遗传育种];
摘要
Unlike HLA-A and HLA-B, few peptide epitope motifs have been reported for HLA-C molecules. However, a number of cytotoxic T-lymphocyte epitopes derived from tumor antigens that bind to HLA-C molecules have been described. Here we report peptide-binding motifs for both HLA-Cw6.02 and HLA-Cw7.01 molecules. Recombinant human HLA molecules were generated and used to screen combinatorial 9mer peptide libraries. Complexes of HLA molecules properly folded and associated with beta(2)-microglobulin and peptides were identified using a conformation-specific HLA class I antibody conjugated to alkaline phosphatase. In the presence of substrate, peptide beads can be readily isolated and microsequenced to determine peptide identity. Of the peptides that bound to HLA-Cw6.02 and HLA-Cw7.01, 19 and 18 peptides, respectively, were sequenced, allowing motif identification for each C allele. This is the first report of an HLA-Cw7.01 peptide motif and extends the findings of Falk et al. [(1993) Proc Natl Acad Sci USA 90:12005] for an HLA-Cw6.02 motif. Anchoring amino acids for the HLA-Cw6.02 motif were phenylalanine or tyrosine in position (P)1, arginine in P2, and an aliphatic/aromatic residue at P9. Anchoring residues for HLA-Cw7.01 were positively charged amino acids in P1 and P2. Unlike most other HLA molecules, we were unable to assign P9 an anchoring residue, and we suspect that HLA-Cw7.01 binds peptides in an unconventional manner. Additionally, preferred amino acids were identified for both molecules. Identification of HLA-Cw6.02 and HLA-Cw7.01 peptide-binding motifs makes a significant contribution to the C allele peptide-binding motifs and will allow investigators to predict, design, and test HLA-Cw6.02 and HLA-Cw7.01 engineered peptides for immunotherapy.
引用
收藏
页码:391 / 398
页数:8
相关论文
共 38 条
[1]
N-linked carbohydrate on human leukocyte antigen-C and recognition by natural killer cell inhibitory receptors [J].
Baba, E ;
Erskine, R ;
Boyson, JE ;
Cohen, GB ;
Davis, DM ;
Malik, P ;
Mandelboim, O ;
Reyburn, HT ;
Strominger, JL .
HUMAN IMMUNOLOGY, 2000, 61 (12) :1202-1218
[2]
Clinical and immunological evaluation of patients with metastatic melanoma undergoing immunization with the HLA-Cw*0702-associated epitope MAGE-A12:170-178 [J].
Bettinotti, MP ;
Panelli, MC ;
Ruppe, E ;
Mocellin, S ;
Phan, GQ ;
White, DE ;
Marincola, FM .
INTERNATIONAL JOURNAL OF CANCER, 2003, 105 (02) :210-216
[3]
Intercellular transfer and supramolecular organization of human leukocyte antigen C at inhibitory natural killer cell immune synapses [J].
Carlin, LM ;
Eleme, K ;
McCann, FE ;
Davis, DM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (10) :1507-1517
[4]
Castelli C, 1999, J IMMUNOL, V162, P1739
[5]
Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL [J].
Chen, JL ;
Dunbar, PR ;
Gileadi, U ;
Jäger, E ;
Gnjatic, S ;
Nagata, Y ;
Stockert, E ;
Panicalli, DL ;
Chen, YT ;
Knuth, A ;
Old, LJ ;
Cerundolo, V .
JOURNAL OF IMMUNOLOGY, 2000, 165 (02) :948-955
[6]
Chiari R, 1999, CANCER RES, V59, P5785
[7]
The transmembrane sequence of human histocompatibility leukocyte antigen (HLA)-C as a determinant in inhibition of a subset of natural killer cells [J].
Davis, DM ;
Mandelboim, O ;
Luque, I ;
Baba, E ;
Boyson, J ;
Strominger, JL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (08) :1265-1274
[8]
Her-2/neu altered peptide ligand-induced CTL responses:: implications for peptides with increased HLA affinity and T-cell-receptor interaction [J].
Dionne, SO ;
Myers, CE ;
Smith, MH ;
Lake, DF .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (04) :307-314
[9]
Functional characterization of CTL against gp100 altered peptide ligands [J].
Dionne, SO ;
Smith, MH ;
Marincola, FM ;
Lake, DF .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2003, 52 (04) :199-206
[10]
Antigen presentation of a modified tumor-derived peptide by tumor infiltrating lymphocytes [J].
Dionne, SO ;
Smith, MH ;
Marincola, FM ;
Lake, DF .
CELLULAR IMMUNOLOGY, 2001, 214 (02) :139-144